Table 2 Comparison of clinical characteristics between the train group and the test group
Covariates | Type | Total | Test | Train | P value |
|---|---|---|---|---|---|
Age | ≤ 65 | 183(40.94%) | 84(37.5%) | 99(44.39%) | 0.1657 |
Age | >65 | 264(59.06%) | 140(62.5%) | 124(55.61%) | |
Gender | FEMALE | 214(47.87%) | 105(46.88%) | 109(48.88%) | 0.7419 |
Gender | MALE | 233(52.13%) | 119(53.12%) | 114(51.12%) | |
Stage | Stage I | 74(16.55%) | 35(15.63%) | 39(17.49%) | 0.5962 |
Stage | Stage II | 176(39.37%) | 85(37.95%) | 91(40.81%) | |
Stage | Stage III | 124(27.74%) | 66(29.46%) | 58(26.01%) | |
Stage | Stage IV | 62(13.87%) | 35(15.63%) | 27(12.11%) | |
Stage | unknow | 11(2.47%) | 3(1.33%) | 8(3.58%) | |
T | T1 | 10(2.24%) | 5(2.23%) | 5(2.24%) | 0.5923 |
T | T2 | 76(17%) | 36(16.07%) | 40(17.94%) | |
T | T3 | 305(68.23%) | 159(70.98%) | 146(65.47%) | |
T | T4 | 56(12.53%) | 24(10.72%) | 32(14.35%) | |
M | M0 | 330(73.83%) | 167(74.55%) | 163(73.09%) | 0.4799 |
M | M1 | 62(13.87%) | 35(15.63%) | 27(12.11%) | |
M | unknow | 55(12.3%) | 22(9.82%) | 33(14.8%) | |
N | N0 | 265(59.28%) | 127(56.7%) | 138(61.88%) | 0.4182 |
N | N1 | 102(22.82%) | 52(23.21%) | 50(22.42%) | |
N | N2 | 80(17.9%) | 45(20.09%) | 35(15.7%) |